Goals
Our goal was to establish Sanskar Jain, CEO and Co-founder of Entvin, as a sharp, forward-thinking voice in the pharmaceutical and regulatory tech landscape. With his background at IIT Bombay and Y Combinator backing, we aimed to showcase his leadership in bringing AI-driven innovation to one of the most rigid industries—pharma compliance.
Industry
Sanskar is leading the charge in regulatory intelligence and AI for pharma. Entvin, under his leadership, is building tools that drastically reduce friction in FDA compliance, transforming regulatory from a blocker into a business enabler. The company sits at the intersection of pharma, compliance, and AI—offering a rich space for insightful thought leadership.
What We Did?
𝗧𝗵𝗲 𝗯𝗶𝗴𝗴𝗲𝘀𝘁 𝘀𝘁𝗮𝗿𝘁𝘂𝗽 𝗺𝘆𝘁𝗵: "𝗥𝗮𝗶𝘀𝗲 𝗺𝗼𝗻𝗲𝘆, 𝗵𝗶𝗿𝗲 𝗮 𝘁𝗲𝗮𝗺, 𝘀𝗰𝗮𝗹𝗲 𝗾𝘂𝗶𝗰𝗸𝗹𝘆.”
Retool, now valued at $3.8B, didn't hire its first employee until 18 months after founding.
Notion operated with a tiny team for years before its explosive growth.
The best companies optimize for timing, not speed.
Building the right team isn't….
25
16
It's been almost a month in San Francisco, and I'm already seeing why Y Combinator strongly encourages founders to stay here after their program ends.
In highly regulated industries like pharma, trust isn’t just about a great product—it’s about deep understanding and credibility.
You can read so much from body language.
It shows which pain points….25
16
Top 10 takeaways from 2025 DIA Advertising and Promotion Conference.
It was great to meet our customers and partners in person.
The industry leaders shared invaluable insights on navigating today's complex pharmaceutical marketing landscape. The discussions were eye-opening and the networking…….
25
16
Our Results
774.8% increased in impressions
Engagements rose by a stunning 1,083.7%
Follower base grew 107.2% turning visibility into community
GSK, a big pharma company has reached out
To increase more reach, outbound has started and gave us more reach
Posting on Pharma and Regulatory groups gave more reach to the profile
Goals
Our goal was to establish Sanskar Jain, CEO and Co-founder of Entvin, as a sharp, forward-thinking voice in the pharmaceutical and regulatory tech landscape. With his background at IIT Bombay and Y Combinator backing, we aimed to showcase his leadership in bringing AI-driven innovation to one of the most rigid industries—pharma compliance.
Industry
Sanskar is leading the charge in regulatory intelligence and AI for pharma. Entvin, under his leadership, is building tools that drastically reduce friction in FDA compliance, transforming regulatory from a blocker into a business enabler. The company sits at the intersection of pharma, compliance, and AI—offering a rich space for insightful thought leadership.
What We Did?
𝗧𝗵𝗲 𝗯𝗶𝗴𝗴𝗲𝘀𝘁 𝘀𝘁𝗮𝗿𝘁𝘂𝗽 𝗺𝘆𝘁𝗵: "𝗥𝗮𝗶𝘀𝗲 𝗺𝗼𝗻𝗲𝘆, 𝗵𝗶𝗿𝗲 𝗮 𝘁𝗲𝗮𝗺, 𝘀𝗰𝗮𝗹𝗲 𝗾𝘂𝗶𝗰𝗸𝗹𝘆.”
Retool, now valued at $3.8B, didn't hire its first employee until 18 months after founding.
Notion operated with a tiny team for years before its explosive growth.
The best companies optimize for timing, not speed.
Building the right team isn't….
25
16
𝗧𝗵𝗲 𝗯𝗶𝗴𝗴𝗲𝘀𝘁 𝘀𝘁𝗮𝗿𝘁𝘂𝗽 𝗺𝘆𝘁𝗵: "𝗥𝗮𝗶𝘀𝗲 𝗺𝗼𝗻𝗲𝘆, 𝗵𝗶𝗿𝗲 𝗮 𝘁𝗲𝗮𝗺, 𝘀𝗰𝗮𝗹𝗲 𝗾𝘂𝗶𝗰𝗸𝗹𝘆.”
Retool, now valued at $3.8B, didn't hire its first employee until 18 months after founding.
Notion operated with a tiny team for years before its explosive growth.
The best companies optimize for timing, not speed.
Building the right team isn't….
25
16
It's been almost a month in San Francisco, and I'm already seeing why Y Combinator strongly encourages founders to stay here after their program ends.
In highly regulated industries like pharma, trust isn’t just about a great product—it’s about deep understanding and credibility.
You can read so much from body language.
It shows which pain points….
25
16
It's been almost a month in San Francisco, and I'm already seeing why Y Combinator strongly encourages founders to stay here after their program ends.
In highly regulated industries like pharma, trust isn’t just about a great product—it’s about deep understanding and credibility.
You can read so much from body language.
It shows which pain points….
25
16
Top 10 takeaways from 2025 DIA Advertising and Promotion Conference.
It was great to meet our customers and partners in person.
The industry leaders shared invaluable insights on navigating today's complex pharmaceutical marketing landscape. The discussions were eye-opening and the networking…….
25
16
Top 10 takeaways from 2025 DIA Advertising and Promotion Conference.
It was great to meet our customers and partners in person.
The industry leaders shared invaluable insights on navigating today's complex pharmaceutical marketing landscape. The discussions were eye-opening and the networking…….
25
16
Our Results
774.8% increased in impressions
Engagements rose by a stunning 1,083.7%
Follower base grew 107.2% turning visibility into community
GSK, a big pharma company has reached out
To increase more reach, outbound has started and gave us more reach
Posting on Pharma and Regulatory groups gave more reach to the profile
774.8% increased in impressions
Engagements rose by a stunning 1,083.7%
Follower base grew 107.2% turning visibility into community
GSK, a big pharma company has reached out
To increase more reach, outbound has started and gave us more reach
Posting on Pharma and Regulatory groups gave more reach to the profile
We
would be
delighted
to
collaborate
with you →
Open to New Projects
We
would be
delighted
to
collaborate
with you →
Open to New Projects
We Would be delighted
to collaborate
with you
Open to New Projects